Daily versus post-dialysis administration of calcimimetics for the treatment of secondary hyperparathyroidism in haemodialysis patients: an interventional, multi-centre study [article retracted]

Authors

  • Tarek M Demerdash
  • Mostafa Abdelsalam
  • Mohammed Assem
  • Mahmoud M Shaheen
  • Mohamed A Marie kasalainy school of medicine ,Cairo university

DOI:

https://doi.org/10.21804/23-1-3728

Abstract

This article has been retracted.


The retraction notice was published on 06 May 2020: 
Retraction notice: Daily versus post-dialysis administration of calcimimetics for the treatment of secondary hyperparathyroidism in haemodialysis patients: an interventional, multi-centre study. Afr J Nephrol. 2020; 2391):85.

Downloads

Download data is not yet available.

Downloads

Published

2020-04-25

How to Cite

Demerdash, Tarek M, Mostafa Abdelsalam, Mohammed Assem, Mahmoud M Shaheen, and Mohamed A Marie. 2020. “Daily Versus Post-Dialysis Administration of Calcimimetics for the Treatment of Secondary Hyperparathyroidism in Haemodialysis Patients: An Interventional, Multi-Centre Study [article Retracted]”. African Journal of Nephrology 23 (1):81-84. https://doi.org/10.21804/23-1-3728.

Issue

Vol. 23 No. 1 (2020)

Section

Original articles